Statistical Methods in Medical Research
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Joint modeling of zero-inflated longitudinal measurements and time-to-event outcomes with applications to dynamic prediction..
9622802241268466.
2024
-
Design and analysis of factorial clinical trials: The impact of one treatment's effectiveness on the statistical power and required sample size of the other.
32:1124-1144.
2023
-
Taking a chance: How likely am I to receive my preferred treatment in a clinical trial?.
32:572-592.
2023
-
Unified approach to optimal estimation of mean and standard deviation from sample summaries.
31:2087-2103.
2022
-
Relative efficiencies of alternative preference-based designs for randomised trials.
29:3783-3803.
2020
-
Robust bivariate random-effects model for accommodating outlying and influential studies in meta-analysis of diagnostic test accuracy studies.
29:3308-3325.
2020
-
Statistical methods for detecting outlying and influential studies in meta-analysis of diagnostic test accuracy studies.
29:1227-1242.
2020
-
Methods for shortening patient-reported outcome measures.
28:2992-3011.
2019
-
Comment to the reply letter: Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019).
28:1603-1603.
2019
-
Decoding and modelling of time series count data using Poisson hidden Markov model and Markov ordinal logistic regression models.
28:1552-1563.
2019
-
Letter to the Editor: Preference option randomized design (PORD) for comparative effectiveness research: Statistical power for testing comparative effect, preference effect, selection effect, intent-to-treat effect, and overall effect (SMMR, Vol. 28, Issue 2, 2019).
28:1597-1598.
2019
-
Joint incorporation of randomised and observational evidence in estimating treatment effects.
28:235-247.
2019
-
Fitting mechanistic epidemic models to data: A comparison of simple Markov chain Monte Carlo approaches.
27:1956-1967.
2018
-
Estimating average attributable fractions with confidence intervals for cohort and case–control studies.
27:1141-1152.
2018
-
Bayesian cure rate models induced by frailty in survival analysis.
26:2011-2028.
2017
-
Cure rate modelling.
26:1999-1999.
2017
-
Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
26:2093-2113.
2017
-
Proportional hazards under Conway–Maxwell-Poisson cure rate model and associated inference.
26:2055-2077.
2017
-
Beyond the treatment effect: Evaluating the effects of patient preferences in randomised trials.
26:489-507.
2017
-
Expectation maximization-based likelihood inference for flexible cure rate models with Weibull lifetimes.
25:1535-1563.
2016
-
A cure rate survival model under a hybrid latent activation scheme.
25:838-856.
2016
-
Reflections on meta-analyses involving trials stopped early for benefit: Is there a problem and if so, what is it?.
22:159-168.
2013
-
A Bayesian destructive weighted Poisson cure rate model and an application to a cutaneous melanoma data.
21:585-597.
2012
-
Meta-analyses of safety data: a comparison of exact versus asymptotic methods.
18:421-432.
2009
-
Using inverse-weighting in cost-effectiveness analysis with censored data.
11:539-551.
2002
-
Spatial heterogeneity, nonlinear dynamics and chaos in infectious diseases.
4:160-183.
1995
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)